HR Execs on the Move

OrthoTennessee

www.orthotn.com

 
OrthoTennessee provides the finest orthopedic clinics in East Tennessee, improving lives through patient-centered care, orthotics, therapy and imaging.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.orthotn.com
  • 256, Fort Sanders West Boulevard
    Knoxville, TN USA 37922
  • Phone: 865.769.4500

Executives

Name Title Contact Details

Similar Companies

Aeryon Labs Inc

Aeryon Labs Inc is a Waterloo, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Virdante Pharmaceuticals

Virdante Pharmaceuticals, Inc. is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Organon

At Organon, we envision a better and healthier every day for every woman. The diversity of our business provides a sustainable engine of growth so we can identify and invest in solutions for women. Our mission is to deliver impactful medicines and solutions for a healthier every day. We believe the journey to improve women`s health is critical to achieving a healthier world. We are united in our drive to better support the health of women within our company and around the globe. Together, we work toward our goal of finding solutions for the healthcare issues that matter most to her, today and every day.

Stone and Magnanini

Stone & Magnanini is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Forma Therapeutics

At FORMA, patients are our purpose. We are dedicated to delivering transformative medicines to patients with cancer and rare diseases. We are a fully-integrated, privately-held clinical stage biopharmaceutical company. A leader in metabolism, epigenetics and protein homeostasis focused on the discovery, development and commercialization of transformative medicines. Our proprietary R&D platform combines deep biology insight, chemistry expertise and clinical development capabilities to create differentiated drug candidates. We have delivered high-value clinical candidates to our partners and generated a broad proprietary portfolio of internal programs, ranging from pre-clinical to pivotal-stage, with the potential to provide profound patient benefit in hematologic, oncologic and metabolic indications.